Hormone-Receptor (+), HER2 (-) Advanced Breast Cancer: The Biology and Treatment Landscape Post-progression after CDK4/6 Inhibition
This educational activity is provided by ESMO through an independent sponsorship by Eli Lilly and Company
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The Colloquia are organised by ESMO and supported by the industry in a unique collaboration making them the perfect complement to the scientific and educational programme of the Congress. The industry has no influence on the content of the programme or speaker selection. All ESMO Colloquia are open to multi-sponsor support and interested sponsors can contact ESMO for more information on future programmes at colloquia@esmo.org.
Santander Auditorium - Hall 5
This educational activity is provided by ESMO through an independent sponsorship by Eli Lilly and Company
Oviedo Auditorium - Hall 3
This educational activity is organised by ESMO and supported by Novocure via a medical grant
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.